Roger Jeffs - Net Worth and Insider Trading

Roger Jeffs Net Worth

The estimated net worth of Roger Jeffs is at least $55 Million dollars as of 2024-11-13. Roger Jeffs is the CEO of Liquidia Corp and owns about 2,400,455 shares of Liquidia Corp (LQDA) stock worth over $26 Million. Roger Jeffs is the Director of Axsome Therapeutics Inc and owns about 167,668 shares of Axsome Therapeutics Inc (AXSM) stock worth over $17 Million. Roger Jeffs is also the President & Co-CEO of United Therapeutics Corp and owns about 27,092 shares of United Therapeutics Corp (UTHR) stock worth over $11 Million. Besides these, Roger Jeffs also holds Dova Pharmaceuticals Inc (DOVA) , Sangamo Therapeutics Inc (SGMO) . Details can be seen in Roger Jeffs's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Roger Jeffs has not made any transactions after 2024-10-14 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Roger Jeffs

Roger Jeffs Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Roger Jeffs owns 7 companies in total, including Albireo Pharma Inc (ALBO) , Axsome Therapeutics Inc (AXSM) , and Dova Pharmaceuticals Inc (DOVA) among others .

Click here to see the complete history of Roger Jeffs’s form 4 insider trades.

Insider Ownership Summary of Roger Jeffs

Ticker	Comapny	Transaction Date	Type of Owner
ALBO	Albireo Pharma Inc	2017-09-27	director
AXSM	Axsome Therapeutics Inc	2024-03-15	director
DOVA	Dova Pharmaceuticals Inc	2019-11-12	director
		2018-02-08	director
		2018-09-07	director
		2015-04-28	director & President and COO
		2024-10-14	director

Roger Jeffs Latest Holdings Summary

Roger Jeffs currently owns a total of 5 stocks. Among these stocks, Roger Jeffs owns 2,400,455 shares of Liquidia Corp (LQDA) as of October 14, 2024, with a value of $26 Million and a weighting of 46.45%. Roger Jeffs owns 167,668 shares of Axsome Therapeutics Inc (AXSM) as of March 15, 2024, with a value of $17 Million and a weighting of 30.34%. Roger Jeffs also owns 27,092 shares of United Therapeutics Corp (UTHR) as of April 28, 2015, with a value of $11 Million and a weighting of 19.75%. The other 2 stocks Dova Pharmaceuticals Inc (DOVA) , Sangamo Therapeutics Inc (SGMO) have a combined weighting of 3.46% among all his current holdings.

Latest Holdings of Roger Jeffs

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
LQDA	Liquidia Corp	2024-10-14	2,400,455	10.64	25,540,841
AXSM	Axsome Therapeutics Inc	2024-03-15	167,668	99.49	16,681,289
UTHR	United Therapeutics Corp	2015-04-28	27,092	400.87	10,860,370
DOVA	Dova Pharmaceuticals Inc	2019-07-01	66,993	28.04	1,878,484
SGMO	Sangamo Therapeutics Inc	2018-09-07	9,908	2.71	26,801

Holding Weightings of Roger Jeffs

Roger Jeffs Form 4 Trading Tracker

According to the SEC Form 4 filings, Roger Jeffs has made a total of 8 transactions in Liquidia Corp (LQDA) over the past 5 years, including 4 buys and 4 sells. The most-recent trade in Liquidia Corp is the sale of 8,053 shares on October 14, 2024, which brought Roger Jeffs around $89,469.

According to the SEC Form 4 filings, Roger Jeffs has made a total of 2 transactions in Axsome Therapeutics Inc (AXSM) over the past 5 years, including 1 buys and 1 sells. The most-recent trade in Axsome Therapeutics Inc is the sale of 32,323 shares on March 15, 2024, which brought Roger Jeffs around $2 Million.

According to the SEC Form 4 filings, Roger Jeffs has made a total of 0 transactions in United Therapeutics Corp (UTHR) over the past 5 years. The most-recent trade in United Therapeutics Corp is the sale of 5,000 shares on April 28, 2015, which brought Roger Jeffs around $816,550.

More details on Roger Jeffs's insider transactions can be found in the Insider Trading History of Roger Jeffs table.

Insider Trading History of Roger Jeffs

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Roger Jeffs Trading Performance

GuruFocus tracks the stock performance after each of Roger Jeffs's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Roger Jeffs is 18.36%. GuruFocus also compares Roger Jeffs's trading performance to market benchmark return within the same time period. The performance of stocks bought by Roger Jeffs within 3 months outperforms 3 times out of 8 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Roger Jeffs's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Roger Jeffs

Average Return

Average return per transaction

Outperforming Transactions

5 out of 6 outperforming transactions.

Each transaction is measured over a period and compared to .

	1 Month	3 Months	6 Months	1 Year	2 Years	3 Years
Return(%)	13.51
Relative Return to S&P 500(%)	14.01

Roger Jeffs Ownership Network

Ownership Network List of Roger Jeffs

No Data

Ownership Network Relation of Roger Jeffs

Roger Jeffs Owned Company Details

What does Albireo Pharma Inc do?

Who are the key executives at Albireo Pharma Inc?

Roger Jeffs is the director of Albireo Pharma Inc. Other key executives at Albireo Pharma Inc include director & President and CEO Cooper Ronald Harold Wilfred , Chief Human Resources Officer Michelle Graham , and CFO and Treasurer Harford Simon N.r. .

Albireo Pharma Inc (ALBO) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Albireo Pharma Inc (ALBO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Albireo Pharma Inc (ALBO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Albireo Pharma Inc (ALBO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Albireo Pharma Inc Insider Transactions

No Available Data

What does Axsome Therapeutics Inc do?

Who are the key executives at Axsome Therapeutics Inc?

Roger Jeffs is the director of Axsome Therapeutics Inc. Other key executives at Axsome Therapeutics Inc include Chief Operating Officer Mark L. Jacobson , General Counsel Hunter R. Murdock , and Chief Financial Officer Nick Pizzie .

Axsome Therapeutics Inc (AXSM) Insider Trades Summary

Over the past 18 months, Roger Jeffs made 1 insider transaction in Axsome Therapeutics Inc (AXSM) with a net sale of 32,323. Other recent insider transactions involving Axsome Therapeutics Inc (AXSM) include a net sale of 80,311 shares made by Mark L. Jacobson , a net sale of 40,085 shares made by Mark Coleman , and a net sale of 11,016 shares made by Mark E Saad .

In summary, during the past 3 months, insiders sold 11,016 shares of Axsome Therapeutics Inc (AXSM) in total and bought 0 shares, with a net sale of 11,016 shares. During the past 18 months, 163,735 shares of Axsome Therapeutics Inc (AXSM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 163,735 shares.

Axsome Therapeutics Inc (AXSM)'s detailed insider trading history can be found in Insider Trading Tracker table.

Axsome Therapeutics Inc Insider Transactions

No Available Data

What does Dova Pharmaceuticals Inc do?

Who are the key executives at Dova Pharmaceuticals Inc?

Roger Jeffs is the director of Dova Pharmaceuticals Inc. Other key executives at Dova Pharmaceuticals Inc include 10 percent owner Joseph Edelman , 10 percent owner Perceptive Advisors Llc , and 10 percent owner Perceptive Life Sciences Master Fund Ltd .

Dova Pharmaceuticals Inc (DOVA) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Dova Pharmaceuticals Inc (DOVA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Dova Pharmaceuticals Inc (DOVA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Dova Pharmaceuticals Inc (DOVA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Dova Pharmaceuticals Inc Insider Transactions

No Available Data

What does Sio Gene Therapies Inc do?

Who are the key executives at Sio Gene Therapies Inc?

Roger Jeffs is the director of Sio Gene Therapies Inc. Other key executives at Sio Gene Therapies Inc include Chief Commercial Officer Parag V Meswani , Chief Executive Officer Pavan Cheruvu , and 10 percent owner Roivant Sciences Ltd. .

Sio Gene Therapies Inc (SIOX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Sio Gene Therapies Inc (SIOX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Sio Gene Therapies Inc (SIOX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Sio Gene Therapies Inc (SIOX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Sio Gene Therapies Inc Insider Transactions

No Available Data

What does Sangamo Therapeutics Inc do?

Who are the key executives at Sangamo Therapeutics Inc?

Roger Jeffs is the director of Sangamo Therapeutics Inc. Other key executives at Sangamo Therapeutics Inc include 10 percent owner Biogen Inc. , SVP-Chief Development Officer Nathalie Dubois-stringfellow , and 10 percent owner Biogen Ma Inc. .

Sangamo Therapeutics Inc (SGMO) Insider Trades Summary

Over the past 18 months, Roger Jeffs made no insider transaction in Sangamo Therapeutics Inc (SGMO). Other recent insider transactions involving Sangamo Therapeutics Inc (SGMO) include a net sale of 6,000,000 shares made by Biogen Inc. ,

In summary, during the past 3 months, insiders sold 0 shares of Sangamo Therapeutics Inc (SGMO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 6,000,000 shares of Sangamo Therapeutics Inc (SGMO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 6,000,000 shares.

Sangamo Therapeutics Inc (SGMO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Sangamo Therapeutics Inc Insider Transactions

No Available Data

What does United Therapeutics Corp do?

Who are the key executives at United Therapeutics Corp?

Roger Jeffs is the director & President and COO of United Therapeutics Corp. Other key executives at United Therapeutics Corp include President and COO Michael Benkowitz , CFO and Treasurer James Edgemond , and director & Chief Executive Officer Martine A Rothblatt .

United Therapeutics Corp (UTHR) Insider Trades Summary

Over the past 18 months, Roger Jeffs made no insider transaction in United Therapeutics Corp (UTHR). Other recent insider transactions involving United Therapeutics Corp (UTHR) include a net sale of 707,954 shares made by Martine A Rothblatt , a net sale of 128,500 shares made by Paul A Mahon , and a net sale of 133,718 shares made by James Edgemond .

In summary, during the past 3 months, insiders sold 182,647 shares of United Therapeutics Corp (UTHR) in total and bought 0 shares, with a net sale of 182,647 shares. During the past 18 months, 1,105,161 shares of United Therapeutics Corp (UTHR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,105,161 shares.

United Therapeutics Corp (UTHR)'s detailed insider trading history can be found in Insider Trading Tracker table.

United Therapeutics Corp Insider Transactions

No Available Data

What does Liquidia Corp do?

Who are the key executives at Liquidia Corp?

Roger Jeffs is the director of Liquidia Corp. Other key executives at Liquidia Corp include V.P. Crp Dvlpmnt and Strtgy Jason Adair , Chief Medical Officer Rajeev Saggar , and SVP & Commercial Scott Moomaw .

Liquidia Corp (LQDA) Insider Trades Summary

Over the past 18 months, Roger Jeffs made 5 insider transaction in Liquidia Corp (LQDA) with a net purchase of 86,616. Other recent insider transactions involving Liquidia Corp (LQDA) include a net sale of 12,844 shares made by Jason Adair , a net sale of 14,116 shares made by Scott Moomaw , and a net sale of 33,720 shares made by Rajeev Saggar .

In summary, during the past 3 months, insiders sold 175,229 shares of Liquidia Corp (LQDA) in total and bought 487,078 shares, with a net purchase of 311,849 shares. During the past 18 months, 307,295 shares of Liquidia Corp (LQDA) were sold and 2,023,391 shares were bought by its insiders, resulting in a net purchase of 1,716,096 shares.

Liquidia Corp (LQDA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Liquidia Corp Insider Transactions

No Available Data

Roger Jeffs Mailing Address

Above is the net worth, insider trading, and ownership report for Roger Jeffs. Currently GuruFocus does not have mailing address information for Roger Jeffs.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.